https://www.selleckchem.com/pr....oducts/trastuzumab-e
Eighty-five percent of patients is potentially exposed to thromboembolic events due to the hypercoagulability state of the disease and different coagulation and fibrinolysis abnormalities (e.g. hyperhomocysteinaemia, protein C and S deficiencies, vitamin K and B deficiencies). Cerebral venous thrombosis is a rare thromboembolic localization. Anticoagulation is efficient in most cases though endovascular treatment might be required. Evolution of celiac disease could be associated with several complications. Eighty-fi
Like
Comment
Share
